CPC A61K 31/5365 (2013.01) [A61K 9/0019 (2013.01); A61K 9/1641 (2013.01); A61K 31/519 (2013.01); A61P 31/18 (2018.01)] | 7 Claims |
1. A method of inhibiting HIV integrase in a subject in need thereof, the method comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
a) a compound of formula I:
![]() or a pharmaceutically acceptable salt thereof, wherein R is a saturated linear aliphatic chain of a length of 17 carbons, and
b) a pharmaceutically acceptable carrier.
|